Latest News

doctor filling biosimilar syringe| Image credit: PhotobyTawat
No Differences in Treatment Persistence, Safety Detected for Anti-TNF Biosimilars vs Originators

June 22nd 2024

A real-world study using data from the French National Health Data System, found no significant differences in treatment persistence or safety between anti-tumor necrosis factor (TNF)-α biosimilars and reference products in all indications of these biologics.

FDA | Image credit: wladimir1804 -
FDA Draft Guidance Removes Switching Study Requirements for Biosimilar Interchangeability

June 20th 2024

doctor and patient | Image credit: sebra -
Switching Patients With IBD to Infliximab, Adalimumab Biosimilars Did Not Impact Efficacy

June 8th 2024

syringes | Image credit: Napat -
New Evidence Confirms Safe Biosimilar-to-Biosimilar Switching

May 28th 2024

Eye on Pharma banner
Eye on Pharma: Simlandi US Launch; Ranibizumab Partnership; Expanded Access for Adalimumab Biosimilars

May 27th 2024

Video Interviews
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner

More News

© 2024 MJH Life Sciences

All rights reserved.